Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jan 30, 2026

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Published on: February 26, 2013

Preface

¹Professor of Pharmacology and Toxicology (Tenured) Robert L. Boblitt Endowed Professor in Drug Discovery Director of UH Drug Discovery Institute University of Houston, Houston, TX 77204, United States.

Current Cancer Drug Targets

|January 24, 2019

Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 30, 2026

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Published on: February 26, 2013

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamics of Anterior Chamber Angle Parameters in Primary and Secondary Pseudophakic Eyes Following Congenital Cataract Surgery.

Translational vision science & technology·2026

Same author

An absolute quantification atlas of small non-coding RNAs across diverse mammalian tissues and cell lines.

Nature communications·2026

Same author

Genetic spectrum of congenital cataract with optional ocular and multisystem abnormalities.

BMC medical genomics·2025

Same author

Preface.

Current cancer drug targets·2025

Same author

Targeting MDM2, RAS, and PCNA for cancer targeted therapy: pan-cancer approaches vs. cancer-specific strategies.

Frontiers in pharmacology·2025

Same author

A comprehensive proteomic analysis uncovers novel molecular subtypes of gastric signet ring cell carcinoma: Identification of potential prognostic biomarkers and therapeutic targets.

Genes & diseases·2025

Same journal

Coordinated Roles of T Cells and Natural Killer Cells in Tumor Immunity.

Current cancer drug targets·2026

Same journal

Multi-omics Signature Predicts Anti-EGFR Therapy Benefit in Colorectal Cancer Liver Metastases: A Multi-center Cohort Study.

Current cancer drug targets·2026

Same journal

Anticancer Effect and Mechanism of Novel c-Myc Inhibitor BP1 on Hepatocellular Carcinoma.

Current cancer drug targets·2026

Same journal

Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic Abilities of Erlotinib in Pancreatic Cancer.

Current cancer drug targets·2026

Same journal

Corrigendum to: Migrasomes: A Novel Target for Cancer Treatment.

Current cancer drug targets·2026

Same journal

Corrigendum to: GPX4 Inhibition Enhances the Antitumor Effect of PARP Inhibitor on Homologous Recombination Proficient Ovarian Cancer Cells.

Current cancer drug targets·2026

See all related articles